Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2021

Apr 2, 2021

34412_dirs_2021-04-01_34348092-889a-4c5a-a821-0ea751458654.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-10-23

Reporting Person: Schor Chen (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-23 Common Stock F 8649 $0.00 Disposed 26070 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 270335 Indirect

Footnotes

F1: The Reporting Person is disposing of 8,649 restricted stock units as a result of a revised tax rate for such restricted stock units.

F2: Represents 85,623 shares held directly by an irrevocable family trust having an independent trustee, 22,985 shares held by a revocable family trust of which the Reporting Person is the trustee, 91,857 shares held directly by an irrevocable family trust having an independent trustee, 23,570 shares held directly by a revocable trust of which the spouse is the trustee, 27,014 held directly by a grantor retained annuity trust of the Reporting Person and 19,286 shares held directly by a grantor retained annuity trust of the spouse.